The risk-benefit ratio of anticonvulsant drugs. - Wikidata - awgldk - TriplyDB

The risk-benefit ratio of anticonvulsant drugs.

The risk-benefit ratio of anticonvulsant drugs.

http://www.wikidata.org/entity/Q39675361

about

Clinimetric analysis of treatment objectives and clinical status: individualized treatment in epileptic patients.Clobazam in Treatment of Refractory Epilepsy: The Canadian Experience. A Retrospecti

P2860

Q52917063-184D3B73-73FC-4A51-B34B-DBD484AFE7AE Q56805040-F7EFF65D-162F-48E6-AD35-66FC8F613D4F

P2860

The risk-benefit ratio of anticonvulsant drugs.

http://www.wikidata.org/entity/Q39675361

description

1987 nî lūn-bûn

@nan

1987年の論文

@ja

1987年論文

@yue

1987年論文

@zh-hant

1987年論文

@zh-hk

1987年論文

@zh-mo

1987年論文

@zh-tw

1987年论文

@wuu

1987年论文

@zh

1987年论文

@zh-cn

name

The risk-benefit ratio of anticonvulsant drugs.

@en

The risk-benefit ratio of anticonvulsant drugs.

@nl

type

label

The risk-benefit ratio of anticonvulsant drugs.

@en

The risk-benefit ratio of anticonvulsant drugs.

@nl

prefLabel

The risk-benefit ratio of anticonvulsant drugs.

@en

The risk-benefit ratio of anticonvulsant drugs.

@nl

P1433

Q39675361-CDC991E0-0FAB-4548-9614-CE319FCD0B27

P1476

Q39675361-ACD597EF-9A6A-4009-845C-ADB6D5F780FA

P2093

Q39675361-7C1D897A-E589-4F38-9897-588482F796B8

P2860

Q39675361-00B95312-F818-4F94-9D80-0448BBC109F3

Q39675361-08CEADE3-EDA9-4703-9C03-454310218CF7

Q39675361-08F342D1-26FE-4A20-A945-25F9A3B3F159

Q39675361-19EB8119-0D13-4B57-B5F0-EBB193D2C55D

Q39675361-1C12706B-E0C1-4B36-B3F9-0C50AD83643B

Q39675361-26FB28CA-4243-40FD-B65A-F937CF51F1D4

Q39675361-2D6199B5-D420-4EFA-B2C9-D4CCC19BE41A

Q39675361-32BD472B-DCC8-4D03-A758-B28A2E46EF3B

Q39675361-33EC4446-F853-4310-923A-0D168C5BD361

Q39675361-3518ADE6-839A-4ED2-91D4-1BEF05A78942

P304

Q39675361-A5333B66-5CC7-4206-A23C-3DADC11C1EF8

P31

Q39675361-ECBB6F42-2812-422C-A700-6B0AF3754169

P356

Q39675361-DBC41F3F-4326-43E7-906C-FDA73CEF1976

P433

Q39675361-F69C6328-8660-4A6B-AEB0-BC342EEFF0AE

P478

Q39675361-C2072031-6821-421A-AF92-CE42884729B4

P577

Q39675361-41201CC7-2FFF-405E-AC84-73EDD16A38F2

P698

Q39675361-3B844BFD-D8C6-4023-BD09-2A1E8284A83E

P356

P1433

Medical toxicology and adverse drug experience

P1476

The risk-benefit ratio of anticonvulsant drugs.

@en

P2093

M J Eadie

http://www.w3.org/2001/XMLSchema#string

P2860

Sequelae after the intravenous injection of three benzodiazepines--diazepam, lorazepam, and flunitrazepam

Tremor due to sodium valproate

Diphenylhydantoin-induced acute renal failure

Phenytoin-induced hyperkinesia

Mephenytoin: a reappraisal

Anticonvulsant-induced dyskinesias: a comparison with dyskinesias induced by neuroleptics

Anticonvulsant peripheral neuropathy: a clinical and electrophysiological study of patients on single drug treatment with phenytoin, carbamazepine or barbiturates

Sodium valproate, platelet dysfunction, and bleeding.

Anticonvulsant serum levels: relationship to impairments of cognitive functioning.

Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically pathologically malignant lymphomas.

P304

324-337

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/BF03259952

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

1987-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

3312929

http://www.w3.org/2001/XMLSchema#string